InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.735
-0.005 (-0.29%)
Nov 4, 2024, 3:59 PM EST - Market closed
Company Description
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.
The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector.
The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
InterCure Ltd.
| Country | Israel |
| Founded | 1994 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 270 |
| CEO | Alexander Rabinovich |
Contact Details
Address: 85 Medinat ha-Yehudim Street Herzliya, 4676670 Israel | |
| Phone | 972 7 746 05012 |
| Website | intercure.co |
Stock Details
| Ticker Symbol | INCR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| CIK Code | 0001857030 |
| CUSIP Number | M549GJ111 |
| ISIN Number | IL0011063760 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Alexander Rabinovich | Chief Executive Officer and Director |
| Amos Cohen | Chief Financial Officer |
| Einat Zehavi | Vice President of Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 28, 2024 | 6-K | Report of foreign issuer |
| Sep 17, 2024 | 6-K/A | Filing |
| Sep 13, 2024 | 6-K | Report of foreign issuer |
| Aug 29, 2024 | 6-K | Report of foreign issuer |
| Aug 28, 2024 | 6-K | Report of foreign issuer |
| May 21, 2024 | 6-K | Report of foreign issuer |
| May 1, 2024 | 6-K | Report of foreign issuer |
| May 1, 2024 | 20-F | Annual and transition report of foreign private issuers |
| May 1, 2024 | NT 20-F | Notification of inability to timely file Form 20-F |
| Apr 1, 2024 | 6-K | Report of foreign issuer |